Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AML

Clinical trial NCT07735117 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07735117
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)

Start date: 2026-07-30
Primary completion: 2028-07-20
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.